4th Congress of Russian Mycologists

The Fourth Congress of Russian Mycologists was convened in Moscow on April 12-14, 2017. The Congresses are the major Russian and Eurasian events in general and medical mycology, summoned by All-Russian National Academy of Mycology once in 5 years. More than 1800 participants attended, making over 280 presentations during 40 sessions, with abstracts and proceedings published in Current Mycology in Russia (vols. 6 and 7) and Advances in Medical Mycology (vol. XVII).

The awards of Academy, A.A. Yachevskiy medal and 'Ob merita in mycologia medica' were bestowed upon renowned researchers, and 14 young mycologists were supported by grants. During the Congress, the Presidium of Academy was elected and a resolution was adopted to develop the international cooperation with focus on Eurasia, to convene a mycological conference in Moscow, 2018 and the Eurasian Mycological Congress in 2019.

Mycoses is no more an Official Journal of ECMM

The official cooperation of ECMM with Mycoses (IF 2.24), the Journal of Confederation for years, is over since the end of 2016. The Confederation now has no official journal. However, organizers of TIMM 2017 still offer publication of electronic abstracts in online edition of Mycoses.

ECMM Educational Symposium on Ecology and Mycology, 14-16 February 2016, Tel-Aviv, Israel

ECMM Educational Symposium on Ecology and Mycology: From the environment to the patient’s bed; 14-16 February 2016, Tel-Aviv, Israel

Scope: Environmental changes have been recognized to exert significant effects on infections and specifically on those caused by fungi. The implications of environmental changes are expressed in different epidemiological patterns, in changes of pathogenic flora in various clinical entities, which in turn may lead to the necessity of different therapeutic approaches.

University of Manchester - Masters in medical mycology 2015-2016 scholarship available

A scholarship for the Masters in Medical Mycology Programme is available for the academic year 2015-2016.

Full details can be found on the website:

ECMM/ESCMID postgraduate course Delhi, 19-21 March 2015 - Presentations online

ESCMID Postgraduate Education Course: Diagnosis and Management of Fungal Infections Both in the West and the East.
For all presentations in session 1-5 see below:

New Mexico VA Health Care System and University of New Mexico seek Academic ID Specialist, open rank

New Mexico VA Health Care System and University of New Mexico are seeking an Academic Infectious Diseases Specialist, open rank. The ideal candidate is an accomplished physician¬-investigator, including NIH or VA funding, and strong productivity as demonstrated by a track record of grants and peer-reviewed publications. Research focus in any aspect of fungal pathogenesis, antifungal drug discovery, clinical investigation of IFI's, or any broad topic related to IFI's is of particular interest. Lab space and startup package will be offered to the qualified candidate.

Fungal Infection Trust in the London marathon this year

The Fungal Infection Trust has supported individuals and teams working on fungal disease for 24 years and provided over £3.5 million in funding. It supports The Aspergillus Website and LIFE initiative. Partly to raise awareness and partly for fundraising, it was awarded a charity place in the London marathon this year. Dr Jenny Long is an ENT trainee and running for the FIT, in a stunning hat! Please support her.



Jenny’s page: http://www.fit.care/

New website SFMM

The new website of the Société Française de Mycologie Médicale (SFMM) which is now in French and English, is online.
on http://sfmm-mycologie-medicale.com you can find all news related to the society, particularly the agenda and the journal.

FDA approved isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis

On March 6, 2014 the FDA approved isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis.
Here you can find the FDA press release


While the aspergillosis indication is based on a large, well-designed randomized clinical trial, the mucormycosis indication is based single arm study results compared to literature data and a comparison with results from the ECMM FungiScope registry. For ECMM this is a unprecedented success in this area.

Oliver A. Cornely
President of the ECMM

Post-Graduate Training Course “Paediatric Mycology”, 12-13 October 2015, Lisbon, Portugal.

It is a great pleasure to invite you to the Post-Graduate Training Course “Paediatric Mycology” organized by European Paediatric Mycology Network (EPMyN). The EPMyN has been launched in 2014 to create a European platform for research and education in paediatric mycology with the ultimate goal to increase our understanding of invasive fungal infections in children and neonates and to improve the outcome.

Syndicate content